XML 22 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Interim Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Mar. 31, 2022
Cash flows from operating activities:      
Net loss $ (6,504,495) $ (18,855,710) $ (84,400,000)
Adjustments:      
Depreciation of property, plant and equipment 401,548 755,675  
Non-cash lease expense 157,881 96,290  
Amortization of intangible assets 479,209 491,565  
Share-based payment 2,706,153 3,080,269  
Impairment loss on inventories 3,079,997 0  
Expected credit losses 15,000 37,485  
Non-employee compensation related to warrants   92,685  
Loss on issuance of derivatives 2,126,955    
Net finance expense 915,098 350,777  
Unrealized foreign exchange (gain) loss (137,909) 868,195  
Change in revaluation of marketable securities   12,212  
Interest received   5,303  
Interest paid   (302,781)  
Revaluation of derivatives (9,523,700) (1,933,330)  
Impairment loss on property, plant and equipment 815,661 529,732  
Payment of lease liabilities   (74,304)  
Income tax expense   12,098  
Net gains from sale of property, plant and equipment (85,002)    
Changes in operating assets and liabilities (828,526) (4,424,058)  
Income taxes paid   (12,098)  
Net cash used in operating activities (7,197,791) (19,269,995) (54,300,000)
Cash flows from investing activities:      
Acquisition of property, plant and equipment   (470,408)  
Acquisition of intangible assets   (73,679)  
Net cash used in investing activities:   (544,087)  
Cash flows from financing activities:      
Withholding taxes paid pursuant to the settlement of non-treasury RSUs   (978,697)  
Issuance of shares and warrants costs (465,211)    
Proceeds from exercise of options and pre-funded warrants 65    
Net cash provided by (used in) financing activities: 4,534,856 (978,697)  
Foreign exchange loss on cash and cash equivalents 168,562 132,415  
Net decrease in cash and cash equivalents (2,494,373) (20,660,364)  
Cash and cash equivalents, beginning of period 8,726,341 59,836,889 59,836,889
Cash and cash equivalents as at June 30, 2022 and 2021 6,231,968 39,176,525 8,726,341
Cash and cash equivalents is comprised of:      
Cash and cash equivalents 6,231,968 $ 39,176,525 $ 8,726,341
Direct Offering      
Cash flows from financing activities:      
Proceeds from the issuance of shares and warrants through a Direct Offering $ 5,000,002